Hambro Perks SPAC Eyes Merger With Biotech Istesso, Sky Says
(Source: Reuters: Health)
Source: Reuters: Health - January 28, 2023 Category: Consumer Health News Source Type: news

J & J, Legend say Carvykti beat standard therapy in earlier-line blood cancer
J&J and Leg­end Biotech’s next step in turn­ing their CAR-T ther­a­py Carvyk­ti in­to a po­ten­tial megablock­buster has suc­ceed­ed, the com­pa­nies said Fri­day. Carvyk­ti achieved the pri­ma­ry end­point — pro­gres­sion-free sur­vival — in an open-la­bel Phase III study test­ing the treat­ment…#biotechs #carvykti #cartitude4 #carvyktisability #compete #bristol #squibb #bigpharma #refractorymm #anticipated (Source: Reuters: Health)
Source: Reuters: Health - January 28, 2023 Category: Consumer Health News Source Type: news

Casey Lynch and her Cortexyme team regroup at Lighthouse for another shot at Alzheimer's
The South San Francisco company is focused on a common mouth bacteria it says is responsible for inflammation in the brain's of Alzheimer's patients. (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - January 28, 2023 Category: Biotechnology Authors: Ron Leuty Source Type: news

US pharma industry seeks R & D policy for India's pharmaceutical sector
Based out of Boston, the USAIC for the last 16 years has been organising the India-US health care summit which is attended by the who's who of the pharma sector from both India and the United States. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - January 28, 2023 Category: Pharmaceuticals Source Type: news

Lab Notes: Wistar researcher gets 'next generation' grant; South Jersey firm raises $3.1M
This week's Lab Notes has items on a national awarded to a Wistar Institute researcher, an advancement in gene sequencing by CHOP researchers, a South Jersey biotech firm raising money, and more. (Source: bizjournals.com Health Care:Physician Practices headlines)
Source: bizjournals.com Health Care:Physician Practices headlines - January 27, 2023 Category: American Health Authors: John George Source Type: news

Roseville's Pine Creek Care Center ordered to pay $30.9 million in wrongful death, elder neglect suit
A lawsuit alleged that the nursing facility was understaffed, and that staff were not adequately supervised or trained, as part of a cost-saving strategy by Pine Creek ’s parent company, Carlsbad-based Plum Healthcare Group. (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - January 27, 2023 Category: Biotechnology Authors: Emily Hamann Source Type: news

Cardiology Practices
Check out the list of cardiology practices in the Triangle. (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - January 27, 2023 Category: Biotechnology Source Type: news

Evusheld Loses U.S. Authorization Since It ’ s Not Effective Against New Variants
AstraZeneca Plc’s COVID antibody drug is no longer authorized for use in the U.S., regulators said Thursday, as it’s unlikely to work against strains of the virus that are now dominant across the country. Astra’s drug, called Evusheld, was authorized in December 2021 to prevent COVID infection in high-risk people, but has been rendered less effective by the virus’ mutations. At this point, fewer than 10% of the variants currently circulating in the U.S. appear to be responsive to Astra’s treatment, the U.S. Food and Drug Administration said in a statement. In the meantime, Astra said in a stat...
Source: TIME: Health - January 27, 2023 Category: Consumer Health News Authors: Madison Muller/Bloomberg Tags: Uncategorized bloomberg wire COVID-19 healthscienceclimate Source Type: news

Janssen Announces Unblinding of Phase 3 CARTITUDE-4 Study of CARVYKTI ® (cilta-cel) as Primary Endpoint Met in Treatment of Patients with Relapsed and Refractory Multiple Myeloma
RARITAN, New Jersey, January 27, 2023 – The Janssen Pharmaceutical Companies of Johnson & Johnson today announced that the Phase 3 CARTITUDE-4 study evaluating CARVYKTI® (ciltacabtagene autoleucel; cilta-cel) versus pomalidomide, bortezomib, and dexamethasone (PVd) or daratumumab, pomalidomide, and dexamethasone (DPd) for the treatment of patients with relapsed and lenalidomide-refractory multiple myeloma met its primary endpoint of significant improvement in progression-free survival (PFS) at the first pre-specified interim analysis. As a result of meeting the primary endpoint, the Independent Data Monitoring Commi...
Source: Johnson and Johnson - January 27, 2023 Category: Pharmaceuticals Tags: Latest News Source Type: news

Bharat Biotech: India launches its first nasal Covid vaccine
The vaccine's maker says it is effective in preventing infection and transmission of the disease. (Source: BBC News | Health | UK Edition)
Source: BBC News | Health | UK Edition - January 27, 2023 Category: Consumer Health News Source Type: news

USFDA gives exception to Glenmark Pharma to supply pneumonia drug from Baddi facility
In a regulatory filing, Glenmark said, "...due to medical necessity and potential drug shortage expectations, the USFDA has provided an exception, which enables the Company to supply Atovaquone Oral Suspension USP 750mg/5ml to the US market". (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - January 27, 2023 Category: Pharmaceuticals Source Type: news

Texas Mutual launches subsidiary offering health insurance for small businesses
Texas Mutual Insurance has hired a former Seton executive to lead a new subsidiary that will offer health insurance options to small businesses. Click through to learn more. (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - January 26, 2023 Category: Biotechnology Authors: Mike Christen Source Type: news

Associated Black Charities loses multimillion-dollar grant contract highlighted in scathing city audit
Associated Black Charities, which in 2019 faced scrutiny for its connection to former Mayor Catherine Pugh's "Healthy Holly" book scandal, had been fiscal agent for the Ryan White federal grant program for at least 18 years. (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - January 26, 2023 Category: Biotechnology Authors: Melody Simmons Source Type: news

Medical tech company Know Labs names new CEO
He replaces Phil Bosua, who has led the Seattle-based public company as CEO since 2018. (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - January 26, 2023 Category: Biotechnology Authors: Rick Morgan Source Type: news

Morrisville biotech plans to accelerate hiring with $25M raise
A biotech in Morrisville hit record revenue in 2022. Now, it's ready to accelerate its growth. (Source: bizjournals.com Health Care News Headlines)
Source: bizjournals.com Health Care News Headlines - January 26, 2023 Category: Health Management Authors: Zac Ezzone Source Type: news